Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle

10.1042/bj2980249

10.1002/9780470123119.ch8

Morris SM, 1994, New insights into the regulation of inducible nitric oxide synthesis, Am J Physiol, 266, E829

10.1016/S0891-5849(98)00092-6

10.1074/jbc.272.17.11147

Moncada S, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, 109

10.1016/S0021-9258(18)47160-8

Grisham MB, 1999, Nitric oxide – I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation, Am J Physiol Gastrointest Liver Physiol, 39, G315, 10.1152/ajpgi.1999.276.2.G315

10.1016/0304-419X(96)00021-2

10.1126/science.276.5321.2034

10.1038/381380a0

10.1152/ajpcell.1996.271.5.C1424

Kubes P, 1995, Excess nitric oxide does not cause cellular, vascular, or mucosal dysfunction in the cat small intestine, Am J Physiol, 269, G34

10.1111/j.1748-1716.1992.tb09359.x

10.1152/ajpgi.1996.270.2.G225

Kubes P, 1992, Nitric oxide modulates epithelial permeability in the feline small intestine, Am J Physiol, 262, G1138

Kanwar S, 1994, Nitric oxide synthesis inhibition increases epithelial permeability via mast cells, Am J Physiol, 266, G222

Brown JF, 1993, Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells, Am J Physiol, 265, G418

10.1152/ajpcell.1996.270.3.C832

10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO;2-G

10.1016/0016-5085(94)90229-1

10.1152/ajplung.1999.277.3.L543

10.1074/jbc.275.15.10826

10.1016/S0140-6736(87)91481-4

10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K

10.1161/01.HYP.23.6.1121

10.1111/j.1440-1746.1995.tb01803.x

Tepperman BL, 1993, Nitric oxide synthase induction and intestinal epithelial cell viability in rats, Am J Physiol, 265, G214

10.1172/JCI117712

10.1172/JCI119473

10.1152/ajpgi.1998.275.3.G564

10.1136/gut.43.1.56

Boughton‐Smith NK, 1994, Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease, J R Soc Med, 87, 312, 10.1177/014107689408700602

10.1016/0140-6736(93)90211-X

10.1016/0140-6736(93)91476-3

10.1016/S0140-6736(94)90460-X

10.1111/j.1476-5381.1995.tb15938.x

10.1016/S0016-5085(96)70055-0

10.1111/j.1365-2362.1996.tb02131.x

10.1074/jbc.272.19.12626

10.1016/0016-5085(94)90614-9

Kolios G, 1998, Mediators of inflammation: production and implication in inflammatory bowel disease, Hepatogastroenterology, 45, 1601

Kolios G, 2000, Interleukin‐13 inhibits nitric oxide production in human colonic mucosa, Hepatogastroenterology, 47, 714

Kubes P, 1993, Ischemia‐reperfusion in feline small intestine: a role for nitric oxide, Am J Physiol, 264, G143

10.1111/j.1476-5381.1990.tb14163.x

10.1074/jbc.270.23.14214

10.1016/0024-3205(89)90540-7

Payne D, 1993, Nitric oxide donors reduce the rise in reperfusion‐induced intestinal mucosal permeability, Am J Physiol, 265, G189

10.1172/JCI115929

10.1016/0016-5085(95)90442-5

10.1136/gut.34.6.814

10.1016/0027-5107(94)90245-3

10.1016/S0016-5085(98)70534-7

10.1006/niox.1997.0160

10.1016/S0002-9343(00)00480-0

10.1016/0016-5085(93)91063-N

10.1053/gast.1997.v113.pm9352850

10.1016/0016-5085(95)90636-3

10.1136/gut.36.5.718

Miller MJ, 1993, Amelioration of chronic ileitis by nitric oxide synthase inhibition, J Pharmacol Exp Ther, 264, 11

Hogaboam CM, 1995, The selective beneficial effects of nitric oxide inhibition in experimental colitis, Am J Physiol, 268, G673

10.1136/gut.37.2.247

10.1016/S0014-2999(97)01246-6

10.1080/003655200750023200

10.1046/j.1365-2036.2000.014s1026.x

10.1046/j.1440-1681.2001.03388.x

Yamaguchi T, 2001, Differing effects of two nitric oxide synthase inhibitors on experimental colitis, Hepatogastroenterology, 48, 118

Zingarelli B, 1998, Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid‐induced colonic damage in rats, J Pharmacol Exp Ther, 287, 1048

10.1080/003655299750024922

10.1046/j.1365-2249.1999.00878.x

Kankuri E, 2001, Suppression of acute experimental colitis by a highly selective inducible nitric‐oxide synthase inhibitor, N‐[3‐(aminomethyl) benzyl]acetamidine, J Pharmacol Exp Ther, 298, 1128

10.1016/S0024-3205(01)01139-0

10.1084/jem.194.9.1207

10.1016/0016-5085(95)90633-9

10.1023/A:1020241028723

10.1038/labinvest.3780454

10.1073/pnas.232583599

10.1111/j.1476-5381.1994.tb14887.x

10.1016/0014-2999(94)00637-M

10.1042/bj3570593

10.1074/jbc.272.14.9030

10.1016/0016-5085(92)91710-L

10.1074/jbc.272.8.4959

10.1136/gut.45.2.199

10.1053/gast.1997.v112.pm9041266

10.1136/gut.45.6.864

10.1152/ajpgi.2000.279.1.G90

10.1016/S0891-5849(01)00565-2

10.1152/ajpgi.00309.2003

10.1016/j.freeradbiomed.2003.09.016

10.1152/ajpgi.00187.2004

10.1046/j.1365-2982.1999.00150.x

Seifter E, 1978, Arginine: an essential amino acid for injured rats, Surgery, 84, 224

10.1152/ajpgi.2000.279.2.G341

10.1016/0014-2999(93)90997-V

10.1016/0016-5085(95)90341-0

10.1067/msy.2000.107372

10.1172/JCI2067

10.1152/ajpheart.1999.277.4.H1600

10.1006/bbrc.1995.1864

Vodovotz Y, 1999, Regulation of transforming growth factor beta 1 by nitric oxide, Cancer Res, 59, 2142

10.1006/niox.2000.0307

10.1006/bbrc.1993.1543

10.1016/S0002-9440(10)65601-5

10.1152/ajpgi.1996.270.2.G225

10.2310/6650.2002.33281

10.1161/01.CIR.0000086321.04702.AC

10.1007/BF02776950

10.1016/0016-5085(90)90290-H

10.1046/j.1365-2249.1998.00728.x

10.3109/00365529209000116

10.1016/0016-5085(94)90813-3

10.1136/gut.43.1.71

10.1016/S1471-4914(03)00052-2